In vitro anti-Helicobacter pylori activity of usnic acid

Phytotherapy Research

Volumn 23, Issue 7, 2009, Pages 955-957

  Safak, Birol ^a   Ciftci, Ihsan Hakki ^a   Ozdemir, Mehmet ^b   Kiyildi, Nilay ^a   Cetinkaya, Zafer ^a   Aktepe, Orhan Cem ^a   Altindis, Mustafa ^a   Asik, Gulsah ^a  

^a AFYON KOCATEPE UNIVERSITY   (Turkey)

^b SELCUK UNIVERSITY   (Turkey)

Author keywords

Clarithromycin; Helicobacter pylori; Usnic acid

Indexed keywords

CLARITHROMYCIN; USNIC ACID;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG POTENTIATION; HELICOBACTER PYLORI; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; USNEA; USNEA DASYPOGA;

ANTI-BACTERIAL AGENTS; BENZOFURANS; CLARITHROMYCIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE, BACTERIAL; HELICOBACTER PYLORI; HUMANS; MICROBIAL SENSITIVITY TESTS; USNEA;

HELICOBACTER PYLORI; USNEA;

EID: 67650169863     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.2690     Document Type: Article

References (39)

1. Alarcon T, Domingo D, Lopez-Brea M. 1999. Antibiotic resistance problems with Helicobacter pylori. Int J Antimicrob Agents 12: 19-26. (Pubitemid 29241820)
2. Behera BC, Verma N, Sonone A, Makhija U. 2005. Evaluation of antioxidant potential of the cultured mycobiont of a lichen Usnea ghattensis. Phytother Res 19: 58-64. (Pubitemid 40444996)
3. Bell GD, Powell KU, Burridge SM et al. 1993. Helicobacter pylori eradication: efficacy and side effect profile of a combination of omeprazole, amoxycillin and metronidazole compared with four alternative regimens. Q J Med 86: 743-750. (Pubitemid 23330224)
4. Broutet N, Tchamgoue S, Pereira E, Lamouliatte H, Salamon R, Megraud F. 2003. Risk factors for failure of Helicobacter pylori therapy results of an individual data analysis of 2751 patients. 2003. Aliment Pharmacol Ther 17: 99-109.
5. Buiatti E, Munoz N, Vivas J, Cano E, Peraza S. 1994. Difficulty in eradicating Helicobacter pylori in a population at high risk for gastric cancer in Venezuela. Cancer Causes Control 5: 249-254. (Pubitemid 24186014)
6. Chopra RN, Chopra IC, Handa KL, Kapur LD. 1958. Chopra's Indigenous Drugs of India. Dhur & Sons Ltd: Calcutta, 1-100.
7. Correche ER, Carrasco M, Escudero ME et al. 1998. Study of the cytotoxic and antimicrobial activities of usnic acid and derivatives. Fitoterapia 69: 493-501. (Pubitemid 29019150)
8. EUROGAST Study Group. 1993. An International Association between Helicobacter pylori infection and gastric cancer. Lancet 341(8857): 1359-1362. (Pubitemid 23159982)
9. Fournet A, Ferreira ME, Rojas de Arias A et al. 1997. Activity of compounds isolated from Chilean lichens against experimental cutaneous leishmaniasis. Comp Biochem Physiol 111: 69-74.
10. Glupczynski Y, Burette A. 1990. Drug therapy for Helicobacter pylori infection: Problems and pitfalls. Am J Gastroenterol 85: 1545-1551.
11. Halici M, Odabasoglu F, Suleyman H, Cakir A, Aslan A, Bayir Y. 2005. Effects of water extract of Usnea longissima on anti-oxidant enzyme activity and mucosal damage caused by indomethacin in rats. Phytomedicine 12: 656-662. (Pubitemid 41169813)
12. Ingolfsdottir K. 2002. Molecules of interest: usnic acid. Phytochemistry 61: 729-736.
13. Ingolfsdottir K, Chung GAC, Skulason VG, Gissurarson SR, Vilhelmsdottir M. 1998. Antimycobacterial activity of lichen metabolites in vitro. Eur J Pharm Sci 6: 141-144. (Pubitemid 28164284)
14. Kupchan SM, Kopperman HI. 1975. l-Usnic acid: tumor inhibitor isolated from lichens. Experientia 31: 625-626.
15. Lacy BE, Rosemore J. 2001. Helicobacter pylori: ulcers and more: the beginning of an era. J Nutr 131: 2789S-2793S. (Pubitemid 32947812)
16. Marshall BJ, Goodwin CS, Warren JR et al. 1988. Prospective double blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori. Lancet 2(8626-8627): 1437-1442. (Pubitemid 19016648)
17. Marshall BJ, Warren JR. 1984. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1: 1311-1315. (Pubitemid 14111103)
18. Miguel G, Faleiro L, Cavaleiro C, Salgueiro L, Casanova J. 2008. Susceptibility of Helicobacter pylori to essential oil of Dittrichia viscosa subsp. revoluta. Phytother Res 22: 259-263.
19. Muller K. 2001. Pharmaceutically relevant metabolites from lichens. Appl Microbiol Biotechnol 56: 9-16.
20. National Committee for Clinical Laboratory Standards. 2002. Performance Standards for Antimicrobial Susceptibility Testing: Twelfth Informational Supplement M100-S12. NCCLS, Wayne, PA, USA.
21. National Committee for Clinical Laboratory Standards. 2002. Reference method for broth microdilution antifungal susceptibility testing of yeasts. Approved standard, M27-A2, 2nd ed. National Committee for Clinical Laboratory Standards, Wayne, PA, USA.
22. Odabasoglu F, Aslan A, Cakir A et al. 2004. Comparison of antioxidant activity and phenolic content of three lichen species. Phytother Res 18: 938-941. (Pubitemid 40052775)
23. Odabasoglu F, Cakir A, Suleyman H et al. 2006. Gastroprotective and antioxidant effects of usnic acid on indomethacin-induced gastric ulcer in rats. J Ethnopharmacol 103: 59-65. (Pubitemid 41681142)
24. O'Gara EA, Hill DJ, Maslin DJ. 2000. Activities of garlic oil, garlic powder, and their diallyl constituents against Helicobacter pylori. Appl Environ Microbiol 66: 2269-2273. (Pubitemid 30253767)
25. Okuyama E, Umeyama K, Yamazaki M, Kinoshita Y, Yamamoto Y. 1995. Usnic acid and diffractaic acid as analgesic and antipyretic components of Usnea diffracta. Planta Med 61: 113-115.
26. Parsonnet J, Friedman GD, Daniel MS et al. 1991. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 325: 1127-1131.
27. Peitz U, Menegatti M, Vaira D, Malfertheiner P. 1998. The European meeting on Helicobacter pylori: therapeutic news from Lisbon. Gut 43: S66-S69. (Pubitemid 28338116)
28. Rauws EA, Langenberg W, Houthoff HJ, Zanen HC, Tytgat GN. 1988. Campylobacter pyloridis-associated chronic active antral gastritis. A prospective study of its prevalence and the effects of antibacterial and antiulcer treatment. Gastroenterology 94: 33-40.
29. Rohdewald P, Beil W. 2008. In vitro inhibition of Helicobacter pylori growth and adherence to gastric mucosal cells by pycnogenol. Phytother Res 22: 685-688.
30. Scirpa P, Scambia G, Masciullo V et al. 1999. A zinc sulphate and usnic acid preparation used as post-surgical adjuvant therapy in genital lesion by human papillomavirus. Minerva Ginekol 51: 255-260.
31. Shibata S, Ukita T, Tamura T, Miura Y. 1948. Relation between chemical constitutions and antibacterial effects of usnic acid and derivatives. Jpn Med J 1: 152-155.
32. Shikov AN, Pozharitskaya ON, Makarov VG, Kvetnaya AS. 2008. Antibacterial activity of Chamomilla recutita oil extract against Helicobacter pylori. Phytother Res 22: 252-253.
33. Suleyman H, Odabasoglu F, Aslan A et al. 2003. Anti-inflammatory and antiulcer effects of aqueous extract of Lobaria pulmonaria. Phytomedicine 10: 552-557.
34. Tabak M, Armon R, Neeman I. 1999. Cinnamon extracts inhibitory effect on Helicobacter pylori. J Ethnopharmacol 67: 269-277. (Pubitemid 29469736)
35. Tabak M, Armon R, Potasman I, Neeman I. 1996. In vitro inhibition of Helicobacter pylori by extracts of thyme. J Appl Bacteriol 80: 667-672.
36. Vartia KO. 1973. Antibiotics in lichens. In The Lichens, Ahmadjian V, Hale ME (eds). Academic Press: New York, 547-561.
37. Warren JR, Marshall BJ. 1983. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 1: 1273-1275.
38. Yamamoto Y, Kinoshita Y, Matsubara H et al. 1998. Screening of biological activities and isolation of biological active compounds from lichens. Rec Res Dev Phytochem 2: 23-34.
39. Yazici K, Aslan A. 2003. Lichens from the regions of Gümü şhane, Erzincan and Bayburt (Turkey). Cryptogam Mycol 24: 287-300.